Skip to main content

Table 2 Cox univariate and multivariate analysis of recurrence free and overall survival in entire cohort

From: Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer

 

BCSS

OS

 

HR (95%CI)

p

RR (95%CI)

p

All patients (n = 359)

   

SNAS

Univariate

Univariate

low

1.00

  

1.00

  

high

2.05(1.27 - 3.31*)

< 0.001

1.51(1.13 - 2.01)

0.005

SNAS

Multivariate*

Multivariate*

low

1.00

  

1.00

  

high

1.84(1.10 - 3.08)

0.020

1.68(1.22 - 2.32)

0.002

All patients (n = 359)

    

CNR

Univariate

Univariate

low

1.00

 

1.00

 

high

0.49(0.29 - 0.81)

0.006

0.85(0.64 - 1.13)

0.267

CNR

Multivariate*

Multivariate*

low

1.00

 

1.00

 

high

0.47(0.27 - 0.82)

0.008

0.73(0.53 - 1.02)

0.067

  1. * Multivariate analysis included adjustment for grade, age, nodal status, ER status, PR status
  2. Her2 and tumour size